MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
0.6700
-0.0060
-0.89%
Opening 11:33 09/28 EDT
OPEN
0.6724
PREV CLOSE
0.6760
HIGH
0.6800
LOW
0.6407
VOLUME
69.77K
TURNOVER
--
52 WEEK HIGH
59.40
52 WEEK LOW
0.6100
MARKET CAP
689.47K
P/E (TTM)
-79.7619
1D
5D
1M
3M
1Y
5Y
1D
Biodexa Pharmaceuticals files to sell 220.42M ordinary shares for holders
TipRanks · 4d ago
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
Barchart · 5d ago
Weekly Report: what happened at BDRX last week (0914-0918)?
Weekly Report · 09/21 09:54
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/17 17:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/17 12:05
Biodexa Enters Warrant Exercise Deal For $2 Mln As Phase 3 For ERapa Progresses; Stock Plunges 25%
NASDAQ · 09/16 20:46
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/16 17:05
Biodexa Pharmaceuticals Secures $2.3 Million Via Warrant Exercise Deal
TipRanks · 09/15 12:47
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.